Mers-CoV ‘On Course’ According to the Published Genomic Replikin Count Predictions of 2012 and 2013

Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009 Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today April 30, 2014 Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak …